Press coverage about Allscripts Healthcare Solutions (NASDAQ:MDRX) has been trending somewhat positive on Saturday, Accern reports. The research group scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned press coverage about the software maker an impact score of 45.0393787860511 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:
A number of equities research analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Friday. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $17.00 target price on shares of Allscripts Healthcare Solutions in a report on Monday, January 8th. Maxim Group reaffirmed a “buy” rating and issued a $20.00 target price on shares of Allscripts Healthcare Solutions in a report on Tuesday. Citigroup began coverage on shares of Allscripts Healthcare Solutions in a report on Thursday, January 4th. They set a “buy” rating for the company. Finally, Royal Bank of Canada set a $19.00 price objective on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a report on Thursday. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $15.53.
Allscripts Healthcare Solutions (NASDAQ MDRX) traded up $0.09 during trading on Friday, reaching $16.03. 1,439,572 shares of the company were exchanged, compared to its average volume of 2,100,914. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.98 and a quick ratio of 0.98. Allscripts Healthcare Solutions has a 12 month low of $11.01 and a 12 month high of $16.12. The stock has a market cap of $2,880.05, a price-to-earnings ratio of -13.82, a P/E/G ratio of 2.25 and a beta of 1.33.
In other news, President Richard J. Poulton sold 15,000 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $14.26, for a total transaction of $213,900.00. Following the transaction, the president now directly owns 1,351,773 shares in the company, valued at $19,276,282.98. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP James Hewitt sold 36,796 shares of the stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the transaction, the senior vice president now owns 181,766 shares in the company, valued at $2,564,718.26. The disclosure for this sale can be found here. Insiders sold a total of 56,796 shares of company stock worth $804,842 over the last three months. 0.75% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This article was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/13/allscripts-healthcare-solutions-mdrx-receives-daily-coverage-optimism-rating-of-0-20.html.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.